Statins have immunomodulatory and clinical effects in RA

被引:0
|
作者
Sarah Price
机构
关键词
D O I
10.1038/nrrheum.2011.65
中图分类号
学科分类号
摘要
引用
收藏
页码:313 / 313
相关论文
共 50 条
  • [31] Immunomodulatory effects of statins and autoimmune rheumatic diseases: Novel intracellular mechanism involved
    Tristano, Antonio G.
    Fuller, Kathy
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2006, 6 (12) : 1833 - 1846
  • [32] Clinical implications of the immunomodulatory effects of macrolides
    Tamaoki, J
    Kadota, J
    Takizawa, H
    AMERICAN JOURNAL OF MEDICINE, 2004, 117 : 5 - 11
  • [33] Statins Have Different Pleiotropic Effects on Human Endothelial Cells
    Lorenz, Florian
    Bahls, Martin
    Ameling, Sabine
    Hammer, Elke
    Strohbach, Anne
    Volker, Uwe
    Dorr, Marcus
    Felix, Stephan B.
    Busch, Raila
    CIRCULATION, 2016, 134
  • [34] Gypenosides might have neuroprotective and immunomodulatory effects on optic neuritis
    Li, Kaijun
    Du, Yi
    Fan, Qian
    Tang, Cheng-Ye
    He, Jian-Feng
    MEDICAL HYPOTHESES, 2014, 82 (05) : 636 - 638
  • [35] Treating influenza with statins and other immunomodulatory agents
    Fedson, David S.
    ANTIVIRAL RESEARCH, 2013, 99 (03) : 417 - 435
  • [36] Have clinical guidelines on use of statins been implemented in primary care?
    Teeling, M
    Bennett, K
    Feely, J
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2004, 57 (05) : 671 - 671
  • [37] Clinical Implications of Pharmacogenetic Variation on the Effects of Statins
    Maggo, Simran D. S.
    Kennedy, Martin A.
    Clark, David W. J.
    DRUG SAFETY, 2011, 34 (01) : 1 - 19
  • [38] RA—lowering cardiovascular risk with statins
    Justin M. S. Lee
    Robin P. Choudhury
    Nature Reviews Rheumatology, 2010, 6 : 123 - 124
  • [39] Metabolic effects of statins and clinical manifestations of atherosclerosis
    Yakovenko, E., I
    Mamedov, M. N.
    RUSSIAN JOURNAL OF CARDIOLOGY, 2012, (02): : 85 - 90
  • [40] Ongoing clinical trials of the pleiotropic effects of statins
    Davignon, Jean
    Leiter, Lawrence
    VASCULAR HEALTH AND RISK MANAGEMENT, 2005, 1 (01) : 29 - 40